Posts Tagged ‘stress’

How Mental Disorders are Manufactured & Marketed “Not in the Mood? You Could Have Hypoactive Sexual Desire Disorder”

Wednesday, May 19th, 2010

U.S. News & World Report
Deborah Kotz
May 19, 2010

Not interested in sex? Perhaps you have a condition called hypoactive sexual desire disorder, caused by a brain chemical imbalance. That’s the message conveyed in a new “educational campaign” launched last week by the Society of Women’s Health Research with actress Lisa Rinna as a celebrity spokesperson talking about “the brain’s potential role in desire.” On the campaign’s new website, you might conclude that if you’re not fantasizing about sex a lot you should definitely talk to your doctor.

You won’t, though, learn about any medications for HSDD—because there are no approved drugs for it. A new drug, called flibanserin, may be approved by the Food and Drug Administration after its advisory committee meets to discuss the drug next month. In the meantime, flibanserin manufacturer Boehringer-Ingelheim has funded an HSDD educational campaign to create demand for the drug, some experts say. And, yes, Rinna is a paid spokesperson.

“It’s like priming the market,” says Lisa Schwartz, an associate professor of medicine at the Dartmouth Institute for Health Policy and Clinical Practice in Lebanon, N.H. “Disease awareness is a very important part of [preparing for] an upcoming ad campaign” for any new drug—which will no doubt occur if and when flibanserin is approved. (I previously reported on the over-medicalization of low sexual desire in women.)

Unfortunately, the website doesn’t provide much useful information about the low sex drive condition, which was first identified in the 1970s and is included in the psychiatric bible, the Diagnostic and Statistical Manual of Mental Disorder. You wouldn’t learn from the website, for example, that certain medications—including antidepressants, birth control pills and antihypertensives—can dampen your sex drive. Nor would you learn about the usefulness of psychological treatments like psychotherapy or mindfulness training. And the website doesn’t differentiate between “situational” HSDD, caused by lifestyle factors like lack of sleep, breastfeeding, stress, and relationship issues, and “generalized” HSDD, which may arise from some sort or physiological problem, like low testosterone levels or a brain chemical imbalance. In this interview with Fox News, Rinna said she lost her sex drive soon after her second child was born, which, according to experts, means she probably had some explainable reason like excess fatigue or low sex hormones due to nursing.

Read entire article: http://health.usnews.com/health-news/family-health/brain-and-behavior/articles/2010/05/19/not-in-the-mood-you-could-have-hypoactive-sexual-desire-disorder.html

« Return to news items


Share

The Mothers Act Disease Mongering Campaign – Part III

Friday, July 31st, 2009

Evelyn Pringle
Natural News.com
July 31, 2009

In an article titled, “Disorders Made To Order,” in the July 2002 issue of Mother Jones Magazine, Brendan Koerner described the “modus operandi” of marketing a disease rather than selling a drug, “typical of the post-Prozac era.”

“The strategy [companies] use-it’s almost mechanized by now,” said the late Dr Loren Mosher, a San Diego psychiatrist and former official at the National Institute of Mental Health, in the article.

“Typically, a corporate-sponsored “disease awareness” campaign focuses on a mild psychiatric condition with a large pool of potential sufferers,” Koerner noted.

“Prominent doctors are enlisted to publicly affirm the malady’s ubiquity,” he said. “Public-relations firms launch campaigns to promote the new disease, using dramatic statistics from corporate-sponsored studies.”

“Companies fund studies that prove the drug’s efficacy in treating the affliction, a necessary step in obtaining FDA approval for a new use, or ‘indication,’” he wrote.

“Finally, patient groups are recruited to serve as the “public face” for the condition, supplying quotes and compelling human stories for the media; many of the groups are heavily subsidized by drugmakers, and some operate directly out of the offices of drug companies’ P.R. firms,” Koerner explained.

The disease focused on in Koerner’s article was generalized anxiety disorder, or GAD. The PR firm credited with orchestrating the successful campaign of selling the disease and Paxil to treat it, was Cohn & Wolfe, working for GlaxoSmithKline.

As an ex-employee of Cohen & Wolfe, Katherine Stone serves well as one of the “public faces” for the Mothers Act disease mongering campaign, complete with her own website, Postpartum Progress.

Read entire article: http://www.naturalnews.com/026742_depression_disease_postpartum_depression.html

« Return to news items


Share